Sunday, June 27, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.

from Tech-Economic Times
via IFTTT

No comments:

Post a Comment